Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T21:10:58.437Z.
Calculation as of: 2026-10-06T21:10:58.437Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6ab3c6c305b7dcf17016c86d2d7a97e6f339495347b2093ee54c38b264d7f501
PEG RATIO
N/A
BioNexus Gene Lab Corp.
Market Cap
$3.00M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| BioNexus Gene Lab Corp. (BGLC) | $3.00M | N/A |
| PTL Limited (PTLE)vs › | $2.98M | N/A |
| Iveda Solutions, Inc. (IVDA)vs › | $3.17M | N/A |
| Polar Power, Inc. (POLA)vs › | $3.17M | N/A |
| Intelligent Group Limited (INTJ)vs › | $2.74M | N/A |
| Globavend Holdings Limited (GVH)vs › | $2.71M | N/A |
| Top KingWin Ltd. Class A (DPU)vs › | $2.66M | N/A |
| DEFSEC Technologies Inc. (DFSC)vs › | $2.64M | N/A |
| Addentax Group Corp. (ATXG)vs › | $3.36M | N/A |
| INLIF Limited (INLF)vs › | $3.60M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
